ImmunXperts, a Q² Solutions Company ImmunXperts, a Q² Solutions Company

Menu
  • Home
  • Services
    • Immunogenicity
    • Immuno-Oncology
    • Cell Therapy
    • ImmunAcademy
  • About Us
    • Team
    • Scientific Advisory Board
  • News & Events
  • Contact Us
  • Careers

You are here:

  1. Home
  2. News & Events
  3. Innate and non-classical immune cells in cancer immunotherapy – Keystone symposia in Keystone

Innate and non-classical immune cells in cancer immunotherapy – Keystone symposia in Keystone

21 March 2019

We will be attending the Innate and non-classical immune cells in cancer immunotherapy Keystone symposia on 24-28 March 2019 in Keystone.

 

Posted in:
  • Events

See more

  1. Prev:European Antibody Therapeutics Xchange 2019
  2. Back: All Posts
  3. Next:15th edition of PEGS Boston

Recent Posts

  • In vitro Immunogenicity and Functional Testing of Nanoparticles, mRNA, and Biologics
  • Happy to join the Nexelis family
  • 11th Open Scientific EIP Symposium on Immunogenicity of Biopharmaceuticals
  • Innovation for Health
  • PEGS Europe, 18-22 November 2019, Lisbon

Categories

  • Events
  • News
  • Uncategorized
 
  • linkedin
  • twitter

Services

  • Immunogenicity
  • Immuno-Oncology
  • Cell Therapy
  • ImmunAcademy

About Us

  • Team
  • Scientific Advisory Board

News & Events

  • News
  • Events
Website by Uchrony
  • Home
  • Contact Us
  • Careers

© ImmunXperts, a Q² Solutions Company | Rue Auguste Piccard 48 6041 Gosselies | +32(0)71960133


Contact Us
Q² Solutions, a wholly owned subsidiary and laboratory division of IQVIA, is a leading global clinical trial laboratory services organization providing comprehensive testing, project management, supply chain, biorepository and specimen management, and clinical trial sample and consent tracking solutions.
Learn more at www.q2labsolutions.com.

Back to Top